Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

NCT: NCT07680283 · RECRUITING

NCT IDNCT07680283
StatusRECRUITING
Start Date2026-07
Completion2029-01
SponsorThe Cleveland Clinic (OTHER)
First posted
Last updated

Brief Summary

This is a Phase II, single-center (Cleveland Clinic), two-arm, randomized, parallel-group superiority trial. The two arms will compare IOUS-guided margin selection against standard macroscopic margin selection in patients undergoing ileocolic resection for terminal ileal Crohn's disease. Patients and outcome assessors (pathologists, endoscopists) will be blinded to the intervention arm, while surgeons, by the nature of the intervention, cannot be blinded. Randomization will be computer-generated with concealed allocation using permuted blocks to ensure balanced group sizes.

Frequently Asked Questions

What is Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD?

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD is a clinical trial registered under NCT07680283. Current status: RECRUITING.

What is the status of NCT07680283?

The current status of NCT07680283 (Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD) is: RECRUITING.

When did Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD start?

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.